Azitromycin efficacy in Bronchial Asthma refractory to conventional therapy
DOI:
https://doi.org/10.31053/1853.0605.v75.n3.17736Keywords:
severe asthma, bronchiectasis, azitromycin,Abstract
Nosotros sugerimos que la TACAR del tórax debió formar parte de la metodología en esta publicación y que constituye una recomendación para la evaluación del Asma refractario al tratamiento en la práctica clínica.
Downloads
References
1. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Powell H, Taylor SL, Leong LEX, Rogers GB, Simpson JL. Lancet 2017; 390: 659–68.
2. Comorbidities in adults with asthma: Population-based cross-sectional analysis of 1.4 million adults in Scotland. Weatherburn CJ, Guthrie B, Mercer SW, Morales DR. Clin Exp Allergy, 2017;1–7.
3. Co-morbidities in severe asthma: Clinical impact and management. Porsbjerg C, Menzies A. Respirology, 2017; 22: 651–661.
4. Investigation of bronchiectasis in severe uncontrolled asthma. Dimakou K, Gousiou A, Toumbis M, Kaponi M, Chrysikos S, Thanos L, Triantafillidou. Clin Respir J. 2017;1–7.
5. Qualitative Analysis of High-Resolution CT Scans in Severe Asthma. Gupta S, Siddiqui S, Haldar P, Raj V, Entwisle JJ, Wardlaw AJ, Bradding P, Pavord ID, Green RH, Brightling CE. CHEST 2009; 136:1521–1528.
6. Bronchiectasthma and asthmectasis. Soriano JB, Serrano J. Eur Respir J 2016; 47: 1597–1600.
7. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, Milne D, Fergusson W, Tuffery C, Sexton P, Storey L, Ashton T. Lancet 2012; 380: 660–67.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The generation of derivative works is allowed as long as it is not done for commercial purposes. The original work may not be used for commercial purposes.
How to Cite
